The Biggest Problem in Health Isn’t Knowledge—It’s Consistency

Dr. Sajad Zalzala breaks down how he went from computer science to medicine—and why conventional “cut it out or block it” care pushed him toward functional medicine and ultimately telehealth. From early work in the 2016–2017 telehealth wave (including Hims & Hers) to launching AgelessRx in 2019, he explains what it actually took to build scalable, focused care across all 50 states. This episode digs into the hottest longevity topics—peptides (and why they’re often misunderstood), the real story behind the Women’s Health Initiative and why HRT is being re-evaluated, plus a blunt warning about TRT injections becoming a long-term commitment. They also touch the “Wild West” reality of stem cells, what’s missing in the data, and why outcomes and shared protocols could define the next era of telehealth. Connect with Dr. Sajad Zalzala LinkedIn:   / szalzalamd   Website: https://myrootcauses.com/ Connect with Steve Sood LinkedIn: www.linkedin.com/in/steve-sood-729559394 Website: https://www.wizlo.com/ ----- Keywords: Sajad Zalzala | Compound Wisdom | Steve Sood | telehealth | telemedicine | longevity medicine | functional medicine | holistic medicine | preventative care | allopathic medicine | AgelessRx | Hims and Hers | Teladoc | Amwell | peptides explained | bioregulatory peptides | sermorelin | ipamorelin | BPC-157 | GLP-1 | semaglutide | tirzepatide | liraglutide | HGH vs peptides | HRT explained | Women’s Health Initiative | menopause | progesterone | estrogen | testosterone | TRT explained | controlled substances telehealth | stem cells explained | umbilical cord stem cells | outcomes registry | protocols | reaction | explained | controversy